Journal article
Acute increases in serum creatinine after starting angiotensin-converting enzyme inhibitor-based therapy and effects of its continuation on major clinical outcomes in type 2 diabetes mellitus: the ADVANCE trial
- Abstract:
-
Discontinuation of angiotensin-converting enzyme (ACE) inhibitor is recommended if patients experience ≥30% acute increase in serum creatinine after starting this therapy. However, the long-term effects of its continuation or discontinuation on major clinical outcomes after increases in serum creatinine are unclear. In the ADVANCE trial (Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation), 11 140 diabetes mellitus patients were randomly assi...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Accepted manuscript, pdf, 193.7KB)
-
- Publisher copy:
- 10.1161/HYPERTENSIONAHA.118.12060
Why is the content I wish to access not available via ORA?
Bibliographic data (the information relating to research outputs) and full-text items (e.g. articles, theses, reports, etc.) arrive in ORA from several different sources. Unfortunately we are not able to make available the full-text for every research output.
Please contact the ORA team (
) if you have queries regarding unavailable content OR if you are aware of a full-text copy we can make available.
) if you have queries regarding unavailable content OR if you are aware of a full-text copy we can make available.
Content may be unavailable for the following four reasons
-
Version unsuitable
-
We have not obtained a suitable full-text for a given research output. See this page for more information.
-
Recently completed
-
Sometimes content is held in ORA but is unavailable for a fixed period of time to comply with the policies and wishes of rights holders.
-
Permissions
-
All content made available in ORA should comply with relevant rights, such as copyright. See this page for more information.
-
Clearance
-
Some thesis volumes scanned as part of the digitisation scheme funded by Dr Leonard Polonsky are currently unavailable due to sensitive material or uncleared third-party copyright content. We are attempting to contact authors whose theses are affected.
Alternative access to the full-text
You may be able to access the full-text directly from the publisher's website using the 'Publisher Copy' link in the 'Links & Downloads' box from a research output's ORA record page. This method may require an institutional or individual subscription to the journal/resource.
Authors
Funding
+ National Health and Medical Research Council of Australia
More from this funder
Funding agency for:
Woodward, M
Grant:
1080206
National Health and Medical Research Council of Australia
More from this funder
Expand funders...
Bibliographic Details
- Publisher:
- American Heart Association Publisher's website
- Journal:
- Hypertension Journal website
- Volume:
- 73
- Issue:
- 1
- Pages:
- 84-91
- Publication date:
- 2018-11-27
- Acceptance date:
- 2018-10-25
- DOI:
- EISSN:
-
1524-4563
- ISSN:
-
0194-911X
- Source identifiers:
-
935227
Item Description
- Keywords:
- Pubs id:
-
pubs:935227
- UUID:
-
uuid:92368217-252c-41eb-8433-fc85765ca4b3
- Local pid:
- pubs:935227
- Deposit date:
- 2018-10-29
Terms of use
- Copyright holder:
- American Heart Association, Inc
- Copyright date:
- 2018
- Notes:
- Copyright © 2018 American Heart Association, Inc. This is the accepted manuscript version of the article. The final version is available online from American Heart Association at: https://doi.org/10.1161/HYPERTENSIONAHA.118.12060
If you are the owner of this record, you can report an update to it here: Report update to this record